Startups
Auron Therapeutics aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells. This transformation, called differentiation therapy, reactivates endogenous cellular programs to elicit tumor cell maturation and reprogram cancer tissue to a more normal phenotype.
Overview
Location
United States, Massachusetts, Wellesley
Employees
11-50
Total raised
$27M
Founded date
2018
Investors 4
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| BrightEdge | brightedgefund.org | |
| Sep 5, 2022 | Arkin Holdings | arkinholdings.com |
| BrightEdge | acsbrightedge.org |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 20, 2022 | Auron Therapeutics Raises $48M in Series A Financing | Auron Therapeutics, a Newton, Mass.-based biopharmaceutical company focused on developing therapies that target dysregulated differentiation and cellular plasticity for treating cancer, closed its $48 million Series A financing round. The r... |
| Auron Therapeutics | “Delivering next-generation cancer therapies targeting cell state” | |
| Auron Therapeutics Closes $12.75 Million Seed Financing to Develop Differentiation Therapies for Treatment of Cancers | Wellesley, Mass., Jan. 27, 2021 – Auron Therapeutics (“Auron”), a biopharmaceutical company focused on developing differentiation therapies for treating cancer, today announced the completion of its $12.75 million seed financing round. Proc... |
Reviews 0
FAQ about Auron Therapeutics
When was Auron Therapeutics founded?
Auron Therapeutics was founded in 2018.
How much funding has Auron Therapeutics raised?
Auron Therapeutics has raised $27M in total across 1 funding round.
Who has invested in Auron Therapeutics?
Parsers VC lists 4 investors of Auron Therapeutics, among them Arkin Holdings and BrightEdge.
What has the press written about Auron Therapeutics?
Parsers VC has collected 4 articles mentioning Auron Therapeutics, among them “Auron Therapeutics Raises $48M in Series A Financing” (Jul 20, 2022) and “Auron Therapeutics”.
Is Auron Therapeutics still active?
Yes, Auron Therapeutics is active; its latest activity on Parsers VC dates from Feb 25, 2025.